Page 76 - Read Online

Page 28 of 35 Boyajian et al. Microbiome Res Rep 2024;3:29 https://dx.doi.org/10.20517/mrr.2024.05

33. Faghfouri AH, Khajebishak Y, Payahoo L, Faghfuri E, Alivand M. PPAR-gamma agonists: potential modulators of autophagy in
obesity. Eur J Pharmacol 2021;912:174562. DOI PubMed
34. Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal
muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev 2017;35:200-21. DOI PubMed
35. Wei S, Nguyen TT, Zhang Y, Ryu D, Gariani K. Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease,
mortality, and management. Front Endocrinol 2023;14:1185221. DOI PubMed PMC
36. Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol
2018;14:513-37. DOI PubMed PMC
37. Polyzos SA, Margioris AN. Sarcopenic obesity. Hormones 2018;17:321-31. DOI PubMed
38. Wagenaar CA, Dekker LH, Navis GJ. Prevalence of sarcopenic obesity and sarcopenic overweight in the general population: the
lifelines cohort study. Clin Nutr 2021;40:4422-9. DOI
39. Gao Q, Mei F, Shang Y, et al. Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin
Nutr 2021;40:4633-41. DOI
40. Donini LM, Busetto L, Bischoff SC, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus
statement. Obes Facts 2022;15:321-35. DOI PubMed PMC
41. Lim S, Kim JH, Yoon JW, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal
Study on Health and Aging (KLoSHA). Diabetes Care 2010;33:1652-4. DOI PubMed PMC
42. Crooks B, Stamataki NS, McLaughlin JT. Appetite, the enteroendocrine system, gastrointestinal disease and obesity. Proc Nutr Soc
2021;80:50-8. DOI PubMed
43. Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S. Microbiome, probiotics and neurodegenerative diseases: deciphering
the gut brain axis. Cell Mol Life Sci 2017;74:3769-87. DOI PubMed
44. Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota.
World J Gastroenterol 2015;21:8787-803. DOI PubMed PMC
45. O'toole PW, Claesson MJ. Gut microbiota: Changes throughout the lifespan from infancy to elderly. Int Dairy J 2010;20:281-91.
DOI
46. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free
mice. Proc Natl Acad Sci U S A 2007;104:979-84. DOI PubMed PMC
47. Rinninella E, Tohumcu E, Raoul P, et al. The role of diet in shaping human gut microbiota. Best Pract Res Clin Gastroenterol
2023;62-3:101828. DOI
48. Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ 2019;7:e7502. DOI PubMed
PMC
49. Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World J Gastroenterol 2021;27:3837-50. DOI PubMed PMC
50. Ling Z, Liu X, Cheng Y, Yan X, Wu S. Gut microbiota and aging. Crit Rev Food Sci Nutr 2022;62:3509-34. DOI
51. Stojanov S, Berlec A, Štrukelj B. The influence of probiotics on the firmicutes/bacteroidetes ratio in the treatment of obesity and
inflammatory bowel disease. Microorganisms 2020;8:1715. DOI PubMed PMC
52. DeJong EN, Surette MG, Bowdish DME. The gut microbiota and unhealthy aging: disentangling cause from consequence. Cell Host
Microbe 2020;28:180-9. DOI PubMed
53. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009;457:480-4. DOI
PubMed PMC
54. Aoun A, Darwish F, Hamod N. The influence of the gut microbiome on obesity in adults and the role of probiotics, prebiotics, and
synbiotics for weight loss. Prev Nutr Food Sci 2020;25:113-23. DOI PubMed PMC
55. Magne F, Gotteland M, Gauthier L, et al. The firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?
Nutrients 2020;12:1474. DOI PubMed PMC
56. Castaner O, Goday A, Park YM, et al. The gut microbiome profile in obesity: a systematic review. Int J Endocrinol
2018;2018:4095789. DOI PubMed PMC
57. Peters BA, Shapiro JA, Church TR, et al. A taxonomic signature of obesity in a large study of American adults. Sci Rep 2018;8:9749.
DOI PubMed PMC
58. Koutoukidis DA, Jebb SA, Zimmerman M, et al. The association of weight loss with changes in the gut microbiota diversity,
composition, and intestinal permeability: a systematic review and meta-analysis. Gut Microbes 2022;14:2020068. DOI PubMed
PMC
59. Vaz M, Pereira SS, Monteiro MP. Metabolomic signatures after bariatric surgery - a systematic review. Rev Endocr Metab Disord
2022;23:503-19. DOI PubMed PMC
60. Tavassol ZH, Ejtahed HS, Atlasi R, et al. Alteration in gut microbiota composition of older adults is associated with obesity and its
indices: a systematic review. J Nutr Health Aging 2023;27:817-23. DOI
61. Kesavelu D, Jog P. Current understanding of antibiotic-associated dysbiosis and approaches for its management. Ther Adv Infect Dis
2023;10:20499361231154443. DOI PubMed PMC
62. Malik JA, Zafar MA, Lamba T, Nanda S, Khan MA, Agrewala JN. The impact of aging-induced gut microbiome dysbiosis on
dendritic cells and lung diseases. Gut Microbes 2023;15:2290643. DOI PubMed PMC
63. Hung CC, Chang CC, Huang CW, Nouchi R, Cheng CH. Gut microbiota in patients with Alzheimer’s disease spectrum: a systematic